Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Neuroprotection for Diabetic Retinopathy: a New Therapeutic Strategy

IP: Rafael Simó Canonge
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 30000
Reference: INT14/00050
Duration: 13/05/2015 - 31/12/2015

Pendent de complimentar

IP: Rafael Simó Canonge
Collaborators: David Martinez Selva, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 101250
Reference: CPII14/00032
Duration: 01/02/2015 - 31/01/2018

Neuroprotección en la retinopatía diabética: una nueva estrategia terapéutica

IP: Rafael Simó Canonge
Collaborators: Miriam Izquierdo Sans
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 83900
Reference: BES-2013-064944
Duration: 07/01/2014 - 06/01/2018

Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary clinical and experimental approach

IP: -
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Joan Montaner Villalonga, Immaculada Raurell Saborit, Joan López Hellin, Antonio González Fernández, Antonia Sambola Ayala, Joaquin Lopez Soriano, Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary c, Antonio Rodríguez Sinovas, Rafael Simó Canonge, Francesc Moreso Mateos, Cristina Hernández Pascual, Anna Penalba Morenilla, Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary c, Neus Bellera Gotarda, Natalia Ramos Terrades, Andreea Ciudin Mihai, Maria Mar Hernandez Guillamon, Meritxell Ibernon Vilaró, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Daniel Serón Micas, María Eugenia Espinel Garuz, Marisol Ruiz Meana, Maria Pilar Delgado Martínez, Irina Betsabe Torres Rodriguez, Javier Inserte Igual, Anna Rosell Novel, Olga Simó Servat, Joan Genescà Ferrer, Mònica Pons Delgado, M Antonieta Azancot Rivero, Maria Nazarena Pizzi, M Antonieta Azancot Rivero
Funding agency: Instituto de Salud Carlos III
Funding: 825000
Reference: PIE13/00027
Duration: 01/01/2014 - 30/06/2018

Related news

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.

The study evaluates elecoglipron and shows improvements in glycemic control and body weight compared with placebo.

The study is expected to contribute to the identification of new therapeutic targets and the development of nutritional strategies to improve health.

Related professionals

Laia Anglada Llistosella

Laia Anglada Llistosella

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
Silvia Sánchez Martín

Silvia Sánchez Martín

Postdoctoral researcher
Peripheral Nervous System
Read more
Sergi Martí Beltran

Sergi Martí Beltran

Senior researcher
Pneumology
Read more
Eric Romera Carvajal

Eric Romera Carvajal

Research technician
Microbiology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.